Cancer predictive studies

Loading...
Thumbnail Image
Date
2020
Authors
Bertolo, Riccardo
Bove, Pierluigi
Candi, Eleonora
Chiocchi, Marcello
Cipriani, Chiara
Di Daniele, Nicola
Ganini, Carlo
Juhl, Hartmut
Melino, Gerry
Editors
Contact
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
DOI (citable link)
ArXiv-ID
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Restricted until
Title in another language
Research Projects
Organizational Units
Journal Issue
Publication type
Journal article
Publication status
Published
Published in
Biology Direct ; 15 (2020). - 18. - BioMed Central. - eISSN 1745-6150
Abstract
The identification of individual or clusters of predictive genetic alterations might help in defining the outcome of cancer treatment, allowing for the stratification of patients into distinct cohorts for selective therapeutic protocols. Neuroblastoma (NB) is the most common extracranial childhood tumour, clinically defined in five distinct stages (1-4 & 4S), where stages 3-4 define chemotherapy-resistant, highly aggressive disease phases. NB is a model for geneticists and molecular biologists to classify genetic abnormalities and identify causative disease genes. Despite highly intensive basic research, improvements on clinical outcome have been predominantly observed for less aggressive cancers, that is stages 1,2 and 4S. Therefore, stages 3-4 NB are still complicated at the therapeutic level and require more intense fundamental research. Using neuroblastoma as a model system, here we herein outline how cancer prediction studies can help at steering preclinical and clinical research toward the identification and exploitation of specific genetic landscape. This might result in maximising the therapeutic success and minimizing harmful effects in cancer patients.
Summary in another language
Subject (DDC)
570 Biosciences, Biology
Keywords
Neuroblastoma, Microbiota, Precision oncology, Omics
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690AMELIO, Ivano, Riccardo BERTOLO, Pierluigi BOVE, Eleonora CANDI, Marcello CHIOCCHI, Chiara CIPRIANI, Nicola DI DANIELE, Carlo GANINI, Hartmut JUHL, Gerry MELINO, 2020. Cancer predictive studies. In: Biology Direct. BioMed Central. 15, 18. eISSN 1745-6150. Available under: doi: 10.1186/s13062-020-00274-3
BibTex
@article{Amelio2020Cance-56994,
  year={2020},
  doi={10.1186/s13062-020-00274-3},
  title={Cancer predictive studies},
  volume={15},
  journal={Biology Direct},
  author={Amelio, Ivano and Bertolo, Riccardo and Bove, Pierluigi and Candi, Eleonora and Chiocchi, Marcello and Cipriani, Chiara and Di Daniele, Nicola and Ganini, Carlo and Juhl, Hartmut and Melino, Gerry},
  note={Article Number: 18}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/56994">
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-25T08:19:52Z</dc:date>
    <dc:contributor>Cipriani, Chiara</dc:contributor>
    <dc:contributor>Di Daniele, Nicola</dc:contributor>
    <dc:rights>Attribution 4.0 International</dc:rights>
    <dc:contributor>Juhl, Hartmut</dc:contributor>
    <dc:contributor>Amelio, Ivano</dc:contributor>
    <dc:contributor>Bove, Pierluigi</dc:contributor>
    <dc:creator>Melino, Gerry</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56994/3/Amelio_2-fcbpjh1tg8x30.pdf"/>
    <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
    <dc:contributor>Melino, Gerry</dc:contributor>
    <dcterms:title>Cancer predictive studies</dcterms:title>
    <dcterms:issued>2020</dcterms:issued>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:abstract xml:lang="eng">The identification of individual or clusters of predictive genetic alterations might help in defining the outcome of cancer treatment, allowing for the stratification of patients into distinct cohorts for selective therapeutic protocols. Neuroblastoma (NB) is the most common extracranial childhood tumour, clinically defined in five distinct stages (1-4 &amp; 4S), where stages 3-4 define chemotherapy-resistant, highly aggressive disease phases. NB is a model for geneticists and molecular biologists to classify genetic abnormalities and identify causative disease genes. Despite highly intensive basic research, improvements on clinical outcome have been predominantly observed for less aggressive cancers, that is stages 1,2 and 4S. Therefore, stages 3-4 NB are still complicated at the therapeutic level and require more intense fundamental research. Using neuroblastoma as a model system, here we herein outline how cancer prediction studies can help at steering preclinical and clinical research toward the identification and exploitation of specific genetic landscape. This might result in maximising the therapeutic success and minimizing harmful effects in cancer patients.</dcterms:abstract>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Cipriani, Chiara</dc:creator>
    <dc:contributor>Chiocchi, Marcello</dc:contributor>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:contributor>Bertolo, Riccardo</dc:contributor>
    <dc:contributor>Candi, Eleonora</dc:contributor>
    <dc:creator>Di Daniele, Nicola</dc:creator>
    <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/56994"/>
    <dc:creator>Candi, Eleonora</dc:creator>
    <dc:creator>Bove, Pierluigi</dc:creator>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/56994/3/Amelio_2-fcbpjh1tg8x30.pdf"/>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2022-03-25T08:19:52Z</dcterms:available>
    <dc:creator>Amelio, Ivano</dc:creator>
    <dc:creator>Juhl, Hartmut</dc:creator>
    <dc:contributor>Ganini, Carlo</dc:contributor>
    <dc:creator>Chiocchi, Marcello</dc:creator>
    <dc:creator>Bertolo, Riccardo</dc:creator>
    <dc:language>eng</dc:language>
    <dc:creator>Ganini, Carlo</dc:creator>
  </rdf:Description>
</rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Contact
URL of original publication
Test date of URL
Examination date of dissertation
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
No
Refereed
Yes